This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as Hybrid Event from 15-19 November 2021
Live In-Person Conference Delivered 15-17 NovemberSheraton Airport Brussels, Belgium

Shiv Krishnan, PhD
Senior Director and Head, Business Development & Licensing-Innovative Technologies at Sanofi


Shiv Krishnan leads Business Development & Licensing for Innovative Technologies in Sanofi. In this capacity, he leads a global search-evaluation-licensing effort focused on technologies that deals with the entire value chain (Research, Development, Manufacturing) of Biologics, Gene Therapy, Drug Discovery and Translational Technologies. He also works closely with innovators in academia and biotech companies to identify exciting breakthroughs that could fill Sanofi’s technology gaps. After graduating with a PhD in biochemistry from the University of Technology, Compiegne, France, Shiv spent the early part of his career in France working as a scientist in biotech at Transgene S.A, and then in the field of vaccines at Sanofi Pasteur. He went on to work at Gencell, the gene therapy division of Rhone Poulenc Rorer-until the creation of Aventis at which point he transferred to the United States. Shiv has been active in developing alliances with academia and biotech for the past 18 years covering the entire partnering value chain. He has a keen interest in breakthrough, translational innovation and the business models that support this. Shiv is active in the innovation ecosystem development and participation at conferences and partnering events.

Agenda Sessions

  • Panel Discussion: Partnering to Commercialise Therapeutic Platform Technologies for Drug Discovery and Development